| Bioactivity | Oleoylcarnitine, the metabolite which accumulates through suppression of fatty acid β-oxidation, can enhance hepatocarcinogenesis via STAT3 activation[1]. | |||||||||
| Invitro | Oleoylcarnitine (AC18:1) (5, 25, 50 µM; 24, 48 hours) concentration significantly increases in the Dih10 cells with stable CPT2 knock down[1].Oleoylcarnitine (5 µM, 24 hours) contributes directly to hepatocarcinogenesis by conferring stem cell properties to cancer cells through STAT3 activation[1]. Cell Viability Assay[1] Cell Line: | |||||||||
| Name | Oleoylcarnitine | |||||||||
| CAS | 38677-66-6 | |||||||||
| Formula | C25H47NO4 | |||||||||
| Molar Mass | 425.64 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
Oleoylcarnitine
CAS: 38677-66-6 F: C25H47NO4 W: 425.64
Oleoylcarnitine, the metabolite which accumulates through suppression of fatty acid β-oxidation, can enhance hepatocarc
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.